Rosenkranz Roberto Pedro

Avg. Two Year Performance

No purchase track record
20% Avg. Sale Return
10% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return(3%)6%(10%)7%20%
Sale Success Rate5 of 105 of 106 of 107 of 109 of 10
Drugs » Biotechnology

Director:

Holdings: 96.1K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--